Five minutes with… Tomas Eriksson of Preelumina
This article was originally published in Clinica
Executive Summary
Tomas Eriksson is the CEO of Swedish preeclampsia diagnosis specialist Preelumina. The firm is developing a test based on a blood sample taken in the early stages of pregnancy. Mr Eriksson has more than 15 years of managerial experience in international business development and marketing, largely within the diagnostics and medtech sectors
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals